| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Director
2 companies
Bentsur Ron serves as a Chairman &CEO at NVCT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 78 buys and 28 sells. Those positions are worth an estimated $83.7M at current prices.
Historically, Bentsur Ron's trades have earned a middling insider score of 64/100 across 73 rated trades. Over a 12-month horizon, 52.8% of those trades were profitable, with an average 12-month return of +6.6%.
The biggest single holding is NVCT (~$82.8M) as Chairman &CEO. Net of sales, the recent Form 4 record there shows accumulation of 392,965 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 200 | $17.49 | $3,498.00 | - | -14.4% | -61.3% | |
| May 16, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 320 | $17.03 | $5,448.00 | - | -11.5% | -60.7% | |
| Mar 23, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 230 | $12.13 | $2,789.90 | - | +46.2% | -25.7% | |
| Mar 21, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 480 | $12.08 | $5,798.40 | - | +45.6% | -29.2% | |
| Mar 20, 2023 | XAIR Beyond Air, Inc. | Director | Buy | 2,300 | $6.48 | $14,904.00 | +1.6% | -3.7% | -76.2% | |
| Mar 15, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 2,160 | $10.86 | $23,464.80 | - | +67.9% | -16.5% | |
| Nov 30, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 150 | $7.45 | $1,117.50 | - | +55.5% | +15.6% | |
| Nov 29, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 450 | $7.41 | $3,334.50 | - | +51.9% | +12.2% | |
| Nov 18, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 750 | $7.23 | $5,425.00 | - | +38.2% | +13.4% | |
| Nov 10, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,000 | $7.07 | $7,070.00 | - | +56.1% | +14.2% |